Finance

Lists
FBIO:NASDAQ
Fortress Biotech Inc
2,15 $
-0,92%
(-0,020) 1D
29 սեպ, 12:23:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIO...
Open
2,20 $
High
2,20 $
Low
2,14 $
Mkt. cap
71,70 մլն
Avg. vol.
341,66 հզր
Volume
109,89 հզր
P/E ratio
0,81
52-wk high
4,53 $
52-wk low
2,14 $
EPS
2,65 $
Beta
1,19
Shares outstanding
33,35 մլն
No. of employees
78
Open
2,20 $
High
2,20 $
Low
2,14 $
Mkt. cap
71,70 մլն
Avg. vol.
341,66 հզր
Volume
109,89 հզր
P/E ratio
0,81
52-wk high
4,53 $
52-wk low
2,14 $
EPS
2,65 $
Beta
1,19
Shares outstanding
33,35 մլն
No. of employees
78
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech Inc
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to FBIO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for FBIO in the last 3 months
Highest
Current 2,15 $
5,00 $ (+132,56%)
Average
5,00 $ (+132,56%)
Lowest
5,00 $ (+132,56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Buy
Maintained
5,00 $
+132,6%
08/24/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
17,00 $
+690,7%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
17,63 մլն
16,08 մլն
16,04 մլն
18,72 մլն
Cost of goods sold
5,96 մլն
5,07 մլն
6,76 մլն
6,95 մլն
Cost of revenue
5,96 մլն
5,07 մլն
6,76 մլն
6,95 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,42 մլն
14,73 մլն
15,89 մլն
20,81 մլն
Operating expense
18,48 մլն
15,80 մլն
17,02 մլն
21,78 մլն
Total operating expenses
24,44 մլն
20,87 մլն
23,78 մլն
28,72 մլն
Operating income
-6,81 մլն
-4,79 մլն
-7,74 մլն
-10,01 մլն
Other non operating income
32,74 մլն
5,00 հզր
152,83 մլն
10,74 մլն
EBT including unusual items
8,85 մլն
-6,21 մլն
142,29 մլն
922,00 հզր
EBT excluding unusual items
23,93 մլն
-6,19 մլն
142,29 մլն
840,00 հզր
Income tax expense
26,00 հզր
-816,00 հզր
5,13 մլն
320,00 հզր
Effective tax rate
0,29%
13,13%
3,61%
34,71%
Other operating expenses
-
-
-
-
Net income
5,85 մլն
-3,94 մլն
110,37 մլն
-468,00 հզր
Net profit margin
33,18%
-24,49%
688,20%
-2,50%
Earnings per share
-
-
-
-
Interest and investment income
736,00 հզր
637,00 հզր
570,00 հզր
1,58 մլն
Interest expense
-2,74 մլն
-2,04 մլն
-3,37 մլն
-1,48 մլն
Net interest expenses
-2,01 մլն
-1,40 մլն
-2,80 մլն
105,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,65 մլն
-3,63 մլն
-6,52 մլն
-8,94 մլն
Gain or loss from assets sale
-
-
-
-82,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps